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ABSTRACT 
Introduction: The role of respiratory physiotherapy (RP) in lower respiratory tract infections 
(LRTI) has been questioned. However, studies have focused on hospitalised patients, and the 
presence/absence of an underlying disease has been neglected.  
Objectives: To assess the effects of a RP session in community patients with LRTI and to 
explore the differences between patients with pneumonia (restrictive disease – AR) and those 
with exacerbations of an obstructive disease (AO). 
Methods: A pre/post-test study was conducted. A RP session was applied to patients with LRTI 
and crackles, wheezes, dyspnoea, perception of sputum and oxygen saturation were collected 
pre/post session. Comparisons were performed using paired t-tests or Wilcoxon tests. 
Results: Thirty patients (14 males, 55.23±17.78yrs) with pneumonia (AR, n=12), exacerbations 
of chronic obstructive pulmonary disease, acute bronchitis and asthma (AO, n=18) were 
enrolled. After treatment, the total sample presented lower wheeze rates at trachea (p=0.02; 
r=-0.54) and less sputum (p=0.01; r=-0.47). AR patients presented a decrease in the number of 
crackles (p<0.05; 0.30<dz<0.26) and number and rate of wheezes at chest locations (p<0.05; -
0.56<r<-0.48). AO patients showed an increase in the number of crackles (p<0.05; 
0.20<dz<0.31), wheeze frequency (p=0.03; r=-0.27) and dyspnoea (p=0.04; r=-0.55); and a 
decrease in the number of wheezes at trachea (p=0.02; r=-0.54). 
Conclusions: RP seems effective in reducing wheezes and perception of sputum in patients 
with LRTI. However, when considering AR and AO diseases separately, further changes in 
respiratory sounds and dyspnoea emerged. This highlights the importance of considering 
subgroups of patients with LRTI to develop RP evidence-base practice. 
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INTRODUCTION 
Lower respiratory tract infection (LRTI) defines a wide range of infectious diseases which 
annually affect 429 million people worldwide(1). Due to its far-reaching spectrum of 
conditions(2, 3), LRTI may present itself in the form of a restrictive disease (e.g., patients with 
pneumonia with no other previous respiratory condition) or as an exacerbation of an 
obstructive disease (e.g., chronic obstructive respiratory diseases). 
LRTI is often characterised by the presence of cough, dyspnoea and sputum(3), compromising 
patients’ wellbeing and functionality(4). Respiratory physiotherapy has shown to be effective 
in relieving such symptoms in patients with stable chronic respiratory diseases(5, 6), however 
its effectiveness in patients with LRTI has been questioned. A recent Cochrane systematic 
review assessing the effectiveness of respiratory physiotherapy in pneumonia has reported no 
effects on patients’ health status(7). However, this review only addressed inpatients, therefore 
the content and structure of the intervention (e.g. techniques, duration and frequency) may 
not be the most adequate for community patients. Also, an emerging body of evidence is 
showing promising results when physiotherapy interventions are applied in acute 
exacerbations of obstructive diseases, at the onset and/or immediately after the 
exacerbation(8-10). Improvements in sputum expectoration, exercise capacity(9, 10) and 
health-related quality of life(9); and decrease risk of future hospital admissions(8, 9), have 
been reported. Although the evidence is still scarce, most patients with LRTI are treated as 
community patients(11) and are living in the community therefore, studies focused on 
developing, implementing and assessing the outcomes of community-based physiotherapy 
programs are needed. 
According to the authors’ best knowledge, there is also no intervention studies in LRTI 
exploring if the absence or presence of an underlying respiratory disease influences the effects 
of the physiotherapy treatment. This is of particular relevance, as different underlying 
pathophysiologies might affect patients’ response to interventions primarily developed to 
resolve the LRTI condition. This evidence would contribute not only to clarify the role of 
physiotherapy in patients with LRTI but also to personalise patient’s treatment according to 
their specific background. 
Therefore, the primary aim of this study was to assess the effects of a respiratory 
physiotherapy session in community patients with LRTI. Additionally, a secondary aim was 
established to explore patients’ response to physiotherapy considering their underlying 
respiratory condition, i.e., restrictive disease with no previous respiratory condition (AR) and 
exacerbations of an obstructive disease (AO). For this purpose, computerised adventitious 
respiratory sounds (i.e., crackles and wheezes) were used as primary outcome measures, 
whilst dyspnoea, perception of sputum and peripheral oxygen saturation were used as 
secondary outcome measures. 
METHODS 
Design and Ethics 
A parallel study with a pre/post-test design, part of a larger randomised controlled trial 
(NCT02053870), was conducted with a sample of patients with LRTI living in the community. 
Patients were classified as restrictive (pneumonia) or obstructive (mucosal infections, acute 
exacerbation of COPD and asthma) based on their health records (i.e., previous diagnosis of 
asthma and COPD or no previous diagnosis of a respiratory disease) and medical note s in the 
emergency department (i.e., diagnosis of a pneumonia, acute exacerbation of COPD or asthma 
and acute bronchitis). Lung function tests were not taken into consideration as they are not 
accurate in the assessment of exacerbated patients(12). 
Before data collection, full approval from the Institutional Ethics Committee (2010-4-14) was 
acquired and patients’ written informed consents were obtained.  
Sample size 
Sample size was calculated to determine the number of participants required to detect a 
significant difference in crackles’ mean number per breathing cycle , detected with 
computerised respiratory sound analysis. This parameter was chosen since previous studies 
conducted in patients with LRTI indicated that this variable significantly changes after 
interventions (effect sizes of 0.74 and 1.65)(13, 14). Data from a pilot study(14) conducted 
with 6 community patients with LRTI was used to compute the required sample size (pre: 
2.15±0.55 vs. post 1.59±1.02; effect size of 0.63) for a power of 95% and an alpha of 0.05. 
Using the sample size calculation of GPower 3 software (University Düsseldorf, Germany), a 
sample of 28 individuals was required. According to the literature, the choice of a study’s 
power depends on the size of the effect to be detected, which in turn is based on clinical 
judgement(15). Specifically in the present study, a single session of physiotherapy was being 
evaluated and thus, small differences in the outcome measures were expected, resulting in 
small effect sizes. Therefore, in order to detect true differences between pre and post 
intervention, a larger power was needed in the sample size calculation. 
Dropout rates were calculated using evidence from long-term rehabilitation programs (i.e., 30-
50%)(16, 17), as no studies reporting on dropout rates in single sessions of respiratory 
physiotherapy were found. Considering that patients with exacerbations are those with higher 
probability to dropout(18), the highest percentage was used and a final sample of 41 
participants was recruited. 
Participants 
Patients were recruited from the emergency department of a general hospital and were 
eligible if they: i) were ≥18 years old; ii) presented cough; and iii) had at least one of the 
following symptoms: sputum, dyspnoea, wheezes or chest pain(3). Exclusion criteria were: i) 
hospital admission; ii) signs of cognitive impairment; iii) being bedridden or dependent on a 
wheelchair; iv) having a score >2 in the CURB criteria(19); and v) presence of comorbidities 
that could interfere with the tests (e.g., previous history of pulmonary lobectomy and current 
history of neoplasia, tuberculosis or other infectious diseases). 
Intervention 
The intervention consisted of conventional medical treatment (i.e., antibiotherapy, 
bronchodilators and rest)(3) plus respiratory physiotherapy. The respiratory physiotherapy 
session was conducted 72h after hospital presentation and was composed of approximately: i) 
5 minutes of breathing retraining techniques to reduce energy costs of breathing(20); ii) 10 
minutes of incentive spirometry to increase pulmonary expansion(21), prevent atelectasis and 
aid airway clearance(22); iii) 10-15 minutes of active cycle of breathing techniques to mobilise 
and clear excess bronchial secretions(23); iv) 15 minutes of exercises for thoracic mobility, 
expansion and flexibility to increase pulmonary volumes(24); and v) 10-15 minutes of 
education about self-clearing techniques and home-based exercises, to ensure an on-going 
effective intervention and to encourage patients’ self-management of the disease. Sessions 
lasted on average 60±15 minutes. The same intervention was applied to all participants as 
prior to the study, it was unknown if patients with or without underlying pathologies would 
respond differently to these physiotherapy techniques. Thus, the intervention was prepared to 
tackle mainly the acute condition.  
Data collection 
Before the session, socio-demographics (gender and age), anthropometric (height and weight), 
activities limitation resulting from dyspnoea (measured with the modified medical research 
questionnaire(25)) and lung function tests, assessed with a portable spirometer (MicroLab 
Micro Medical 36-ML3500-MK8, UK)(26), were collected. Information on computerised 
respiratory sounds (collected before lung function tests), dyspnoea, perception of sputum and 
peripheral oxygen saturation were collected before and after the respiratory physiotherapy 
session. Data were collected by an independent trained researcher not involved in the 
respiratory physiotherapy intervention. 
Primary outcome measure 
Computerised adventitious respiratory sounds (i.e, crackles and wheezes), were recorded 
according to the Computerised Respiratory Sound Analysis (CORSA) guidelines for short-term 
acquisitions(27), i.e., participants were in a seated-upright position and respiratory sounds 
were collected with a digital stethoscope (WelchAllyn Meditron 5079-400) in seven anatomical 
locations (trachea, left and right: anterior, lateral and posterior locations). The stethoscope 
was connected to a sound card (Cakewalk UA-25EX), which was plugged to a laptop computer. 
Data were acquired using the LungSounds@UA interface(28) for 20 seconds in each location. 
The signal was converted with a 24-bit resolution at a sampling rate of 44.1 KHz and recorded 
in wav. format(29). Acquired signals were then filtered using a Blackman bandpass filter from 
100-2000Hz. Tracheal data were not analysed for crackles parameters, as a recent study has 
indicated that crackles are not reliable at this anatomical point(30). 
All sound files were analysed using automatic algorithms implemented in Matlab 2009 (The 
MathWorks, Inc, Natick, MA, USA). Breathing cycles were semi-automatically detected using 
the algorithm developed by Huq and Moussavi (95.5% sensitivity and 95.6% specificity)(31). 
Crackles were automatically detected using an algorithm based on fractal dimension and box 
filtering techniques (89% sensitivity, 95% positive predictive value and 92% overall 
performance – F-index)(32). Crackles analysis was composed by number, frequency (Hz), initial 
deflection width (IDW), two-cycle deflection duration (2CD) and largest deflection width 
(LDW). Wheezes detection was performed based on the algorithm of Taplidou and 
Hadjileontiadis(33). The parameters extracted were: total number, number of monophonic 
and polyphonic wheezes, frequency (Hz) and occupation rate. All respiratory sound analysis 
was performed per breathing phase (inspiration/expiration).  
Secondary outcome measures 
Dyspnoea was assessed with the modified Borg Scale(34), a vertical scale labelled from 0 to 10 
with corresponding verbal expressions of increasing breathlessness intensity. The modified 
Borg Scale is simple, quick to apply and has shown to be reliable to assess dyspnoea in subjects 
with respiratory diseases(35, 36). 
Perception of sputum was evaluated using a 5 level self-report scale which is a domain of the 
Breathlessness, cough and sputum scale(37): (1) no sputum production; (2) mild sputum 
production; (3) moderate sputum production; (4) severe sputum production; and (5) 
unquantifiable. This scale is validated for patients with stable COPD(38) and has been shown to 
be sensitive to changes during the course of exacerbations(37). 
Peripheral Oxygen saturation (SpO2) was measured with a pulse oxymeter (Nonin, WristOx 2
™, 
Model 3150) to ensure patient’s safety and monitor the impact of the intervention (i.e., when 
secretions are removed, regional ventilation may increase and oxygenation should improve). 
Pulse oximeters have been described as an accurate outcome measure(39). 
Statistical analysis 
Descriptive statistics were used to characterise the sample. First, differences between pre/post 
physiotherapy session were explored in all sample with paired sample t-tests for normally 
distributed data and Wilcoxon signed-rank tests for ordinal/non-normally distributed data. Chi-
square tests were used for categorical data. Then, two-way analysis of variance with repeated 
measurements were used to establish the significant effects of the interaction time X group. 
For non-parametric and ordinal data, the differences between pre and post-intervention 
assessments were pooled and then Mann Whitney U-tests were used to compare AR and AO 
groups. Pre/post differences within groups were performed using paired sample t-tests, for 
normally distributed data, and Wilcoxon signed-rank tests, for non-normally distributed data. 
The level of significance was set at 0.05. Statistical analysis was completed with the estimation 
of effect sizes for each outcome measure(40). Effect sizes were measured via Partial eta-
squared (ƞ2), for two-way analysis of variance(41), Cohen’s dz for Paired sample t-tests(42) and 
the rank-biserial correlation (r) for data analysed with Mann Whitney U-tests and Wilcoxon 
signed-rank tests(43). Effect sizes were interpreted as small (ƞ2≥0.01; dz≥0.2(42); r≥0.1(43)), 
medium (ƞ2≥0.06; dz≥0.5(42); r≥0.3(43)) or large (ƞ
2≥0.14; dz≥0.8(42); r≥0.5(43)) effect, 
according to the index used. Analyses were performed using SPSS version 20.0 (IBM 
Corporation, Armonk, NY, USA) and data is presented as mean (standard deviation) or median 
[interquartile range]. 
RESULTS 
A total of 41 patients were assessed for eligibility and asked about their willingness to 
participate. Eleven patients refused to participate due to: personal reasons (n=1), transport 
constraints (n=3) and disruption of normal routine (n=7). Thus, 30 community patients (14 
males; 55.23 (17.78) yrs) diagnosed with LRTI were enrolled in the study. Twelve participants 
presented an AR (i.e., pneumonia with no previous respiratory conditions; n=12) and eighteen 
an AO (i.e., exacerbation of COPD, acute bronchitis and asthma) disease. At baseline, no 
significant differences were found between the two groups for socio-demographic and clinical 
characteristics. A detailed description is provided in table 1. 
(please insert table 1 about here) 
Primary outcome measure 
No differences were found in crackles parameters before and after the physiotherapy session 
considering the average changes among the 30 participants (p>0.05). However, when 
considering AR and AO diseases as separate groups, a significant decrease in the number of 
crackles during inspiration (pre 2.01 (1.46) vs. post 1.61 (1.14); p=0.03; dz=0.30) and expiration 
(pre 2.38 (1.67) vs. post 1.98 (1.36); p=0.04; dz=0.26) were found after the intervention in 
patients with AR diseases. Conversely, patients with AO diseases presented a significant 
increase in the same parameter (inspiration: pre 1.89 (1.10) vs. post 2.15 (1.44); p=0.03; 
dz=0.20; expiration: pre 2.64 (1.68) vs. post 3.22 (1.99); p<0.001; dz=0.31) (Figure 1). Also, 
significant differences were found between groups for these variables (p<0.05; ƞ2 from 0.05 to 
0.09). No differences were found within AR and AO groups for the remaining crackles 
parameters. A detail description of crackles variables can be found in the online 
supplementary material. 
(please insert figure 1 about here) 
Considering the average changes among the 30 participants, a significant decrease in the 
wheeze occupation rate at trachea was found (pre 2.36 [0 to 5.83] vs. post 0.70 [0 to 2.79]; 
p=0.02; r=-0.54). No differences were found for the other wheezes’ parameters at trachea or 
at chest locations (p>0.05). However, when considering AR and AO diseases as separate 
groups, a significant decrease in the inspiratory number of wheezes (pre 0.20 [0.20 to 0.50] vs. 
post 0 [0 to 0.20]; p=0.02; r=-0.54), monophonic wheezes (pre 0.20 [0.20 to 0.33] vs. post 0 [0 
to 0.20]; p= 0.01; r=-0.48) and wheeze occupation rate (pre 3.86 [2.15 to 11.87] vs. post 0 [0 to 
3.07]; p=0.01; r=-0.56) at chest locations was observed in AR patients. In AO patients, only the 
frequency (Hz) of inspiratory wheezes increased significantly (pre 233.98 [172.86 to 603.55] vs. 
post 504.35 [226.08 to 911.43]; p=0.03; r=-0.27) (Figure 2).  
(please insert figure 2 about here) 
At trachea, a significant decrease in the expiratory number of wheezes (pre 0.22 [0 to 0.50] vs. 
post 0 [0 to 0.25]; p=0.02; r=-0.54), monophonic wheezes (pre 0 [0 to 0.20] vs. post 0 [0]; p= 
0.02; r=-0.54) and wheeze occupation rate (pre 3.49 [0 to 5.83] vs. post 0 [0 to 2.08]; p=0.02; 
r=-0.55) was observed only in AO patients (Figure 3). 
(please insert figure 3 about here) 
Significant differences between groups were found only in chest locations for the previous 
reported variables (p<0.05; ƞ2 from 0.02 to 0.37). No differences between AR and AO groups 
for the remaining parameters of wheezes were found. More details on wheezes variables can 
be found in the online supplementary material. 
Secondary outcome measures 
Considering the average changes among the 30 participants, a significant improvement in the 
reported sputum was found (pre 3 [2 to 3] vs. post 2 [2 to 3]; p=0.01; r=0.47). When AR and AO 
diseases were analysed as separate groups, patients with AO diseases reported significantly 
less perception of sputum (pre 3 [2 to 3.25] vs. post 2 [1 to 3]; p=0.04; r=0.55) and no 
differences were found for patients with AR diseases. After intervention, AO patients felt more 
breathless than before the intervention (pre 0 [0 to 2] vs. post 2 [1 to 3]; p=0.02; r= 0.47) and 
no significant changes were found for SpO2 in both groups (Table 2). No differences were 
found between groups for these variables. 
(Please insert table 2 about here) 
DISCUSSION 
According to the authors’ best knowledge, this is the first study reporting the effects of one 
single respiratory physiotherapy session in community patients with LRTI.  The expiratory 
wheeze rate at trachea and the self-reported sputum improved significantly in the overall 
sample. No other significant differences were found pre/post intervention when analysing all 
sample. However, when the presence/absence of an underlying disease was taken into 
consideration, opposite behaviours mainly concerning computerised adventitious respiratory 
sounds in chest locations and dyspnoea were found in patients with AR and AO diseases. This 
highlights the importance of exploring the different groups when studying the effects of 
respiratory physiotherapy in patients with LRTI.  
Two cross sectional and descriptive studies developed by Murphy et al. (2004)(44) and 
Vyshedskiy et al. (2011)(45) found that crackles were the most common finding in patients 
with pneumonia, with a mean number ranging from 6 to 8 crackles per patient. Such is 
approximately three times higher than the values obtained in our sample. However, it should 
be noted that in the present study patients were being treated in a community based setting, 
presented mild severity pneumonia (i.e., CURB<2) and were under the effects of the standard 
medical treatment for 72 hours, which most likely influenced the respiratory sounds obtained. 
Contrary to our findings, a study of Piirila (1992)(46) assessing computerised crackles 
behaviour during the clinical course of pneumonia showed that the number of crackles did not 
vary during the course of pneumonia. However, direct comparisons are difficult to establish 
due to methodological constrains. In Piirila’s study(46), patients’ second evaluation was 
performed two days after the initial assessment, whilst in our study the second evaluation 
occurred immediately after the intervention. Also, as the respiratory physiotherapy session 
involved pulmonary expansion and airway clearance techniques, at the end of the session 
more airways were probably clear and open, justifying the reduction in crackles number in the 
AR patients(47). On the other hand, the number of crackles increased in those with AO 
diseases. Exacerbations of obstructive respiratory diseases are characterised by an excessive 
production of thicker sputum, (48, 49), which often remains lodged in the lung bases(49), 
causing small airways to be closed. It is known that respiratory physiotherapy aids to mobilise 
secretions to the upper airways and ultimately clear them from the respiratory system(10). 
This movement of secretions to the upper airways may have contributed for allowing more air 
to pass into smaller and peripheral airways leading them to suddenly open, and therefore 
increasing crackle production. These results also differ from those found by Marques et al. 
(2012)(50), who found no differences in the number of crackles after 20 minutes of active 
breathing cycle techniques in patients with stable bronchiectasis. Differences may be related 
to the different population studied (stable vs. exacerbated) and with the fact that only one 
intervention with a shorter period of time was applied in Marques ’ study. 
Results on wheeze parameters were more discrete, but generally its behaviour supported 
crackles findings. The decrease in the inspiratory number and occupation rate of wheezes in 
patients with AR diseases may support the idea that more airways were open after treatment, 
causing less bronchiolar constriction(51). The significant increase in the frequency of wheezes 
in the chest of patients with AO may be explained by the movement of secretions to more 
central and upper airways, as it is known that high frequency wheezes are produced in more 
proximal airways(52). A significant decrease in the expiratory number of wheezes was also 
observed at trachea. Wheezes’ production in patients with obstructions diseases is related 
with either airways oedema or sputum accumulation(53). In pre-intervention, AO patients 
showed more signs of obstruction, caused by bronchial secretions(54, 55) (i.e., higher rates of 
self-reported sputum, higher percentage of the breathing cycle occupied by wheezes and 
lower FEV1 values). Thus, these findings corroborate the conclusions, that post treatment 
sputum was being moved and eliminated towards more proximal airway. 
Following the respiratory physiotherapy session, all patients reported less sputum and patients 
with AO diseases reported more dyspnoea. A lower sputum perception at the end of the 
session was expected and desirable, as it reveals that the respiratory manoeuvres helped 
patients to expectorate and clean most secretions. These results contrast with a recent 
Cochrane systematic review which reported that respiratory physiotherapy did not improve 
sputum weight in inpatients with pneumonia(7). This may be explained not only by the 
different population studied (i.e., inpatients vs. community patients), but also by the different 
techniques and evaluation methods used. The studies included in the Cochrane review used 
mainly conventional techniques and therefore, those, have been discouraged by the current 
literature in patients with acute respiratory disease (grade B)(23).  
The increase of dyspnoea in AO patients may be explained by the respiratory manoeuvres used 
to mobilise and expel secretions, namely forced expiratory manoeuvres. As previously 
mentioned, AO patients showed more signs of obstruction, thus a higher number of forced 
expiratory manoeuvres were needed to remove secretions. These techniques, despite 
presenting high efficacy(56), also require high levels of physical effort(57), which may explain 
the higher post intervention dyspnoea. Contrarily, Marques et. al (2012)(50) found a 
significantly decrease in patients’ dyspnoea after the airway clearing session. Differences in the 
population, techniques and time of the intervention may explain the dissimilarities between 
studies.  
Currently, there has been a large debate on the effects of respiratory physiotherapy in patients 
with acute and exacerbated conditions. However, based on the best evidence available of the 
effectiveness of physiotherapy techniques to manage the symptoms of LRTI (23, 24, 58) and 
from our results, it can now be suggested that community patients with LRTI may benefit from 
respiratory physiotherapy sessions. Nevertheless, patients with AR diseases may require 
respiratory physiotherapy interventions focused on exercises for thoracic mobility, expansion 
and flexibility to increase pulmonary volumes, reduce number of crackles and open airways, 
whereas patients with AO diseases may need interventions mainly involving techniques for 
airway clearance to move and expel secretions towards proximal airways.  
Limitations and future work 
This study has some limitations that need to be acknowledged. Firstly, the absence of a control 
group. Inclusion of a group of patients receiving only medication would have strengthened the 
findings regarding the effectiveness of respiratory physiotherapy in patients with LRTI. 
Secondly, respiratory sounds parameters were evaluated before and after the respiratory 
physiotherapy session and not between techniques, which impairs to assess the individual 
effect of each technique. However, in clinical practice, one session of respiratory 
physiotherapy often includes more than one technique applied to the patient, which makes 
the results of this study directly applicable to physiotherapists’ clinical practice. Thirdly, it is 
known that factors such as age and severity of the disease affect respiratory sounds(59, 60). 
However, the results achieved for the established groups (i.e., AR vs AO groups) were generally 
homogeneous within groups and a clear difference between them was found, which lead us to 
believe that the influence of such variables was residual. Nevertheless, future studies with 
larger samples are needed to increase the statistical power and allow to control for such 
confounders. 
Finally, flows and/or volumes were not controlled during respiratory sounds recordings. These 
might have affected the results as it is known that crackle frequency depends on volume of 
inhaled air and the presence of wheezes depends on rate of inhalation. However, patients with 
LRTI often present severe dyspnoea which causes the use of a mouthpiece or facemask 
(necessary to assess flows and/or volumes) to be highly uncomfortable or even not tolerated. 
Furthermore, the primary purpose of this study was to assess the effect of respiratory 
physiotherapy applied in a community-based clinical setting, where control of airflow is often 
not practical. 
CONCLUSION 
One session of respiratory physiotherapy seems effective in reducing wheezes rate at trachea 
and perception of sputum in patients with LRTI. However, when considering patients with AR 
and AO diseases separately different responses were observed and further changes in 
respiratory sounds at chest locations and dyspnoea emerged. These results highlight the 
importance of analysing patients with LRTI in subgroups to clarify and develop respiratory 
physiotherapy evidence-base practice in acute respiratory populations. It also emphasises the 
need of implementing personalised care in future interventions applied to community patients 
with LRTI. 
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Figures captions 
 
Figure 1 – Mean number of crackles in patients with acute restrictive and acute obstructive 
diseases. Data are presented as median and 5-95% percentile. Significant differences are 
identified with * (p<0.05). 
 Figure 2 – Wheezes occupation rate in patients with acute restrictive and acute obstructive 
diseases. Data are presented as median and 5-95% percentile. Significant differences are 
identified with * (p<0.05). 
 Figure 3 – Wheezes occupation rate in patients with acute restrictive and acute obstructive 
diseases at trachea. Data are presented as median and 5-95% percentile. Significant 
differences are identified with * (p<0.05). 
 
Tables with captions 
Table 1 - Socio-demographic and clinical characteristics of the participants (n=30). 
 Total Sample 
Acute 
Restrictive 
Acute 
Obstructive 
p 
N. of subjects 30 12 18 - 
Gender (M/F) 14/16 6/6 8/10 - 
Age (yrs)  55.23 (17.78) 52.83 (17.91) 56.83 (18.02) 0.56 
BMI (Kg/m2) 28.24 (4.85) 26.88 (5.32) 29.15 (4.44) 0.21 
mMRC 2 [1-3] 1 [0-2] 2 [1-3] 0.11 
FEV1pp (%) 73.87 (21.03) 80.58 (21.90) 69.39 (19.78) 0.16 
FVC pp (%) 79.37 (20.86) 82.67 (23.10) 77.17 (19.60) 0.56 
FVC/FEV1 76.37 (9.61) 80.50 (6.72) 73.61 (10.39) 0.30 
Note: values show as n, mean (standard deviation) or median [interquartile range].  
Abbreviations: (M/F) – (Male/Female); BMI - body mass index; mMRC - Modified British 
Medical Research Council questionnaire; FEV1pp - forced expiratory volume in one second 
percentage predicted; FVF pp – forced vital capacity percentage predicted. 
 
Table 2 – Descriptive and inferential statistics for the modified Borg scale, sputum and 
peripheral oxygen saturation. 
Clinical 
variables 
Total Sample 
n=30 
Acute Restrictive 
n=12 
Acute Obstructive 
n=18 
 pre post p pre post p pre post p 
MBS 0 [0 to 2] 1 [0-2] 0.13 1 [0 to 2] 1 [0 to 2] 0.32 0 [0 to 2] 1.50 [0 to 2.25] 0.02* 
Sputum 3 [2 to 3] 2 [2 to 3] 0.01* 2.50 [2 to 3] 2 [2 to 3] 0.68 3 [2 to-3.25] 2 [1 to 3] 0.04* 
SPO2  96.31 (2.16) 96.24 (2.81) 0.85 96.67 (2.31) 96 (3.84) 0.38 96.06 (2.08) 96.39 (1.85) 0.32 
Note: values show as mean (standard deviation) or median [interquartile range]. 
Abbreviations: MBS – modified Borg Scale; SpO2 - peripheral oxygen saturation. 
* statistical differences between pre and post intervention (p0.05). 
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Table 1 1 
Table 1 - Summary results of the automatic crackles detection for chest locations at pre and post respiratory physiotherapy session (ri ght and left: anterior, 2 
lateral and posterior areas) during inspiration and expiration. 3 
 CRACKLES 
variables 
Total Sample 
n=30 
Acute Restrictive 
n=12 
Acute Obstructive 
n=18 
  pre post p pre post p pre post p 
In
sp
ir
a
ti
o
n
 Number 1.94 (1.25) 1.94 (1.35) 1.00 2.01 (1.46) 1.61 (1.14) 0.03* 1.89 (1.10) 2.15 (1.44) 0.03* 
IDW (ms) 2.51 (0.77) 2.48 (0.79) 0.64 2.60 (0.70) 2.45 (0.75) 0.07 2.46 (0.82) 2.48 (0.83) 0.80 
LDW (ms) 2.53 (0.59) 2.53 (0.56) 0.86 2.60 (0.60) 2.64 (0.51) 0.91 2.49 (0.59) 2.46 (0.59) 0.90 
2CD (ms) 10.39 (2.43) 10.26 (2.46) 0.07 10.80 (2.30) 10.57 (2.17) 0.38 10.12 (2.51) 10.05 (2.64) 0.69 
Frequency (Hz) 220.59 (141.85) 218.47 (147.63) 0.65 208.70 (140.06) 213.40 (165.35) 0.40 225.43 (140.44) 221.04 (136.67) 0.92 
Ex
p
ir
a
ti
o
n
 Number 2.54 (1.67) 2.72 (1.86) 0.17 2.38 (1.67) 1.98 (1.36) 0.04* 2.64 (1.68) 3.22 (1.99) >0.001* 
IDW (ms) 2.72 (0.74) 2.56 (0.74) 0.10 2.77 (0.69) 2.60 (0.73) 0.27 2.69 (0.78) 2.53 (0.76) 0.12 
LDW (ms) 2.61 (0.58) 2.69 (0.53) 0.44 2.68 (0.55) 2.77 (0.54) 0.34 2.57 (0.59) 2.63 (0.52) 0.09 
2CD (ms) 10.79 (2.46) 10.83 (2.25) 0.34 11 (2.37) 11.06 (2.17) 0.51 10.63 (2.52) 10.66 (2.32) 0.92 
Frequency (Hz) 207.85 (132.15) 194.98 (99.10) 0.15 197.06 (87.32) 199.36 (124.24) 0.62 215.73 (155.46) 192.87 (79.35) 0.11 
Note: values are show as mean (standard deviation). 4 
Abbreviations: IDW - initial deflection width; LDW - largest deflection width; 2CD - two-cycle deflection duration. 5 
* statistical differences between pre and post intervention (p<0.05) 6 
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Table 2 1 
Table 2 - Summary results of the automatic wheeze detection for chest locations at pre and post respiratory physiotherapy session (right and left: anterior, 2 
lateral and posterior) during inspiration and expiration. 3 
 WHEEZE  
variables 
Total Sample 
n=30 
Acute Restrictive 
n=12 
Acute Obstructive 
n=18 
  pre post p pre post p pre post p 
In
sp
ir
a
ti
o
n
 
Number 0.11 [0 to 0.25] 0.10 [0 to 0.25] 0.31 0.20 [0.20 to 0.50] 0 [0 to 0.20] 0.01* 0 [0 to 0.20] 0.13 [0 to 0.25] 0.20 
mWh 0.10 [0 to 0.25] 0 [0 to 0.25] 0.38 0.20 [0.20 to 0.33] 0 [0 to 0.20] 0.01* 0 [0 to 0.20] 0.11 [0 to 0.25] 0.26 
pWh 0 [0] 0 [0] 0.58 0 [0] 0 [0] 0.07 0 [0] 0 [0] 0.27 
%Wh 2.15 [0 to 5.79] 2.22 [0 to 4.58] 0.19 3.86 [2.15 to 11.87] 0 [0 to 3.07] 0.01* 0 [0 to 3.69] 2.58 [0 to 5.74] 0.30 
Frequency 
(Hz) 
282.70 [172.87 
to 501.97] 
480.21 [226.08 to 
911.43] 
0.07 257.26 [173.26 to 
501.97] 
468.58 [213.29 to 
845.02] 
0.78 
233.98 [172.86 to 
603.55] 
504.35 [226.08 to 
911.43] 
0.03* 
Ex
p
ir
a
ti
o
n
 
Number 0.20 [0 to 0.50] 0.20 [0.11 to 0.35] 0.79 0.13 [0.13 to 0.50] 0.16 [0.13 to 0.33] 0.59 0.20 [0.12 to 0.43] 0.25 [0 to 0.40] 0.20 
mWh 0.20 [0 to 0.33] 0.18 [0 to 0.33] 0.37 0.13 [0 to 0.50] 0.16 [0 to 0.33] 0.62 0.20 [0 to 0.33] 0.20 [0 to 0.33] 0.11 
pWh 0 [0 to 0.12] 0 [0] 0.66 0 [0] 0 [0] 0.50 0 [0 to 0.13] 0 [0 to 0.11] 0.97 
%Wh 2.74 [0 to 6.24] 2.94 [1.55 to 6.70] 0.85 2.51 [0 to 5.51] 3.07 [2.16 to 4.87] 0.88 3.07 [2.09 to 6.91] 2.84 [0 to 7.97] 0.16 
Frequency 
(Hz) 
409.73 [249.96 
to 535.32] 
397.01 [203.39 to 
596.02] 
0.28 407.22 [288.03 to 
551.20] 
430.63 [222.49 to 
597.09] 
0.79 
412.23 [224.21 to 
536.26] 
369.45 [196.45 to 
557.38] 
0.83 
Note: values are show as median [inter-quartile range]. 4 
Abbreviations: mWh – number of monophonic wheezes; pWh – number of polyphonic wheezes; %Wh – wheeze occupation rate. 5 
* statistical differences between pre and post intervention (p<0.05). 6 
 7 
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Table 3 1 
Table 3 - Summary results of the automatic wheeze detection at trachea in pre and post respiratory physiotherapy session during inspiration and expiration. 2 
 WHEEZE 
variables 
Total Sample 
n=30 
Acute Restrictive 
n=12 
Acute Obstructive 
n=18 
  pre post p pre post p pre post p 
In
sp
ir
a
ti
o
n
 
Number 0 [0 to 0.20] 0 [0 to 0.13] 0.50 0 [0 to 0.38] 0 [0 to 0.08] 0.14 0 [0 to 0.20] 0 [0 to 0.21] 0.57 
mWh 0 [0 to 0.20] 0 [0 to 0.13] 0.51 0 [0.20 to 0.33] 0 [0 to 0.08] 0.14 0 [0 to 0.05] 0 [0 to 0.14] 0.48 
pWh 0 [0] 0 [0] 1 0 [0] 0 [0] 0.32 0 [0] 0 [0] 0.66 
%Wh 0 [0 to 5.38] 0 [0 to 3.35] 0.36 0 [0 to 0.38] 0 [0 to 1.93] 0.14 0 [0 to 4.62] 0 [0 to 3.92] 0.96 
Frequency 
(Hz) 
319.20 [240.48 to 
557.63] 
410.74 [181.87 to 
573.38] 
0.72 450.61 [197.95 to 
898.77] 
474.29 [195.13 to 
599.71] 
0.66 
319.20 [248.19 to 
485.70] 
347.19 [142.11 to 
564.59] 
0.18 
Ex
p
ir
a
ti
o
n
 
Number 0.16 [0 to 0.43] 0.06 [0 to 0.25] 0.06 0.05 [0 to 0.31] 0.13 [0 to 0.28] 0.67 0.22 [0 to 0.50] 0 [0 to 0.25] 0.02* 
mWh 0.11 [0 to 0.33] 0 [0 to 0.25] 0.14 0.05 [0 to 0.23] 0.13 [0 to 0.24] 0.40 0.20 [0 to 0.43] 0 [0 to 0.25] 0.20 
pWh 0 [0] 0 [0] 0.11 0 [0] 0 [0] 0.66 0 [0 to 0.20] 0 [0] 0.02* 
%Wh 2.36 [0 to 5.83] 0.70 [0 to 2.79] 0.02* 1.01 [0 to 6.27] 2.19 [0 to 5.13] 0.56 3.49 [0 to 5.83] 0 [0 to 2.08] 0.02* 
Frequency 
(Hz) 
356.34 [285.87 to 
551.59] 
384.57 [285.29 to 
819.05] 
0.25 530.19 [306.73 to 
866.70] 
384.57 [210.48 to 
507.33] 
0.89 
325.02 [285.21 to 
504.33] 
422.89 [289.33 to 
876.44] 
0.25 
Note: values are show as median [inter-quartile range]. 3 
Abbreviations: mWh – number of monophonic wheezes; pWh – number of polyphonic wheezes; %Wh – wheeze occupation rate. 4 
* statistical differences between pre and post intervention (p<0.05). 5 
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